Dialysis Adequacy & Kt/V

The contract between this chapter and the reader.

1. 1. Define adequacy as more than a single dose number.
2. 2. Calculate and interpret the urea reduction ratio and single-pool Kt/V.
3. 3. Explain post-dialysis urea rebound and equilibrated Kt/V.
4. 4. Use standard weekly Kt/V to compare dose across frequencies.
5. 5. Sample post-dialysis blood correctly.
6. 6. Incorporate residual kidney function into the delivered dose.
7. 7. Apply dose targets without shortening time to meet them.
8. 8. Recognise what Kt/V does not measure.
9. 9. Construct an adequacy-assessment schedule and act on it.

A sixty-second reading. Each bullet stands alone.

• Adequacy is euvolemia, clearance, nutrition, mineral-bone health, symptoms, and survival together — not a single number.
• Small-solute dose is a minimum to clear, not the goal of dialysis.
• The urea reduction ratio is (pre minus post) over pre; the usual minimum is at least 65%.
• Single-pool Kt/V is derived from pre- and post-dialysis urea, time, and ultrafiltration; the minimum is about 1.2 per session, often targeted near 1.4.
• After dialysis, urea rebounds from tissues into blood, so equilibrated Kt/V — about 0.2 lower — reflects the true dose better.
• Standard weekly Kt/V allows dose to be compared fairly across different frequencies.
• Correct post-dialysis sampling (a slow-flow or stop-pump method) is essential; sloppy sampling falsely inflates the dose.
• Residual kidney clearance adds to dose and can justify a lower prescribed dose or incremental HD when substantial.
• Do not shorten treatment time just because a Kt/V target is met — time has value beyond small-solute clearance.
• Kt/V measures urea only; it captures nothing about middle molecules, phosphate, volume, or blood pressure.
• Randomised evidence shows a higher dose does not improve survival — meet the floor and attend to the clinical domains.
• Twice-weekly HD is acceptable only with substantial residual function.
• A normal Kt/V in an overloaded, wasting, or symptomatic patient is not adequate dialysis.

The medical core. An expert should agree adequacy assessment is fully covered here.

Why it matters at the bedside

Kt/V is the number every unit reports and the one most likely to mislead. It measures how much urea was cleared — useful, but a floor, not the goal. Read it for what it is, sample it honestly, and never let it stand in for the fuller question: is this dialysis keeping the patient well?

What adequacy means

• Adequate dialysis is clinical: a euvolemic, well-nourished patient with controlled mineral-bone disease, few uraemic symptoms, and a clearance that meets a minimum. Each domain can fail on its own, so each is judged in its own right; a patient above every numeric target can still be inadequately dialysed.

Measuring the dose: URR and Kt/V

• The simplest measure is the urea reduction ratio — the fractional fall in urea across a session — with a usual minimum of at least 65%. The standard measure is the single-pool Kt/V, computed from pre- and post-dialysis urea with treatment time and ultrafiltration; the minimum for thrice-weekly HD is about 1.2 per session, often targeted nearer 1.4.

Single-pool, rebound, and equilibrated Kt/V

• The single-pool model assumes urea sits in one compartment, but in reality it rebounds: after dialysis, urea redistributes from cells and poorly-perfused tissues back into the blood over 30–60 minutes, so the post sample taken immediately understates true urea. Equilibrated Kt/V corrects for this and runs about 0.2 below the single-pool value — a better reflection of the dose actually delivered.

Standard weekly Kt/V and frequency

• Per-session Kt/V cannot fairly compare a thrice-weekly schedule with a daily or nocturnal one. The standard weekly Kt/V converts any schedule to a common weekly figure, which is how frequent and nocturnal regimens are dosed and compared.

Sampling correctly

• Dose is only as honest as the post-dialysis sample. Drawing it at full blood-flow contaminates it with dialysed blood and access recirculation, falsely raising the apparent dose; a slow-flow or stop-pump technique with consistent timing gives the true value. A surprisingly good Kt/V often means a sampling error, not good dialysis.

Residual kidney function

• Residual renal urea clearance adds to the delivered dose and, when substantial, can justify a lower prescribed dialysis dose or an incremental schedule — even twice-weekly. As in PD, it is worth preserving and measuring; in anuric patients it is absent and the dialysis must do all the work.

Targets and the value of time

• Meet the minimum — a single-pool Kt/V of at least 1.2 and a URR of at least 65% — but do not treat the number as the ceiling, and never shorten the session below a minimum time just because the target is met. Time clears middle molecules and phosphate, allows gentler fluid removal, and carries value the urea number cannot see.

What Kt/V does not measure

• Kt/V is a urea number. It says nothing about middle molecules, phosphate, fluid removal, blood pressure, or nutrition. The randomised dose trial drove the point home: raising the small-solute dose above target did not improve survival, because the things that matter most are not what Kt/V counts.

When you feel the dialysis is inadequate

• A symptomatic patient with an adequate Kt/V is a prompt to look elsewhere — volume overload, anaemia, acidosis, mineral-bone disease, depression, or intercurrent illness — each of which can mimic underdialysis and each of which has its own treatment.

Evidence base

• The minimum dose targets rest on guideline consensus anchored to outcome data; the futility of exceeding them rests on a large randomised trial; the rebound correction rests on kinetic studies; and the survival value of residual function rests on consistent cohort data.

Five fully-built tables.

Table A — Domains of adequacy

Table B — Dose measures

Table C — Kinetic measures

Table D — Post-dialysis sampling

Table E — Frequency and residual function

Visualise & Map

Numbered rules. These numbers are the cross-reference handle for the cases and flowcharts.

Clinical Reasoning

Four cases. Each stops you at a decision before it answers it.

Exhaustive. Every threshold and rule in the chapter is here.

Safety & Evidence

Panel A — Red flags

Panel B — NEVER DO

Anti-patterns clinicians fall into. Each becomes a Level 22 distractor.

The grade reflects strength of evidence, not importance.

Patient Decisions

Outcomes as natural frequencies. Figures are representative; the direction of effect is given where precise numbers are uncertain.

Apply & Test

Included by author decision: an adequacy review is a real chart note.

Template 1 — Adequacy review note

• Dose: URR ___; spKt/V ___; eKt/V ___; (stdKt/V if non-thrice-weekly) ___.
• Sampling verified (slow-flow/stop-pump): yes/no.
• Volume: BP ___; weight/oedema ___ — euvolemic? yes/no.
• Nutrition ___; mineral-bone (phosphate/PTH) ___; symptoms ___.
• Residual renal clearance: ___ — incorporated? yes/no.
• Assessment: adequate / inadequate (domain ___); action and next review ___.

Template 2 — Dose / sampling discrepancy note

• Reported dose and change from prior: ___.
• Sampling technique used: ___ (full-flow error suspected? yes/no).
• Re-sampled correctly: result ___.
• Access recirculation assessed: ___.
• Corrected dose acted upon; prescription change (if any): ___.

Pre-rounds compression. Numbers and rules only.

Active recall. At least one card per objective.

Micro-teaching for rounds. Two scenarios, five steps each.

Metacognition anchored to this chapter's tensions. No answers provided.

1. 1. A single number is easy to chart and audit; how do you keep Kt/V from quietly becoming the definition of ‘good dialysis’ on your unit?
2. 2. Time helps most and is the easiest to cut when a Kt/V is already met; how do you protect it against the pressure to shorten sessions?
3. 3. A flattering dose can come from a careless sample; how confident are you that your unit's post-sampling is honest, and how would you check?
4. 4. Residual function lets you do less, yet it is rarely measured once a patient is established; what would it take to make incremental HD routine?
5. 5. When a patient with a perfect Kt/V still feels terrible, where do you look first — and what does that say about what dialysis is for?

Nine items, each anchored in this chapter. At least one per objective.